1 active not recruiting, 1 recruiting, 1 terminated, 1 unknown. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Active not recruiting 1, Recruiting 1, Terminated 1, Unknown 1 |
Follow Prosthesis Failure: new trials by email Literature Review of Prosthesis Failure trials Research Report on Prosthesis Failure
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nutrition Impact on Immunotherapy of Cancer Megestrol Acetate and olanzapine, Starch powder 50 mg - Nutrition Disorders, Immunotherapy | Phase 3 | Recruiting | Qingdao Central Hospital | 300 | 2024-06-01 | 2024-07-15 |
| Local Antibiotics for Breast Implants Gentamicin, Cefazolin and Vancomycin, Placebo - Implant Complication, Implant Infection | Phase 3 | Active not recruiting | Mikkel Herly | 1003 | 2021-01-27 | 2026-09-29 |
| Efficacy of Risedronate in Patients With Painful Periprosthetic Resorption of the Hip Prothesis risedronate, placebo - Prosthesis Loosening | Phase 3 | Terminated | University Hospital, Limoges | 3 | 2016-05-01 | 2018-10-17 |
| A Phase III Study of Nimotuzumab Plus Concurrent Chemoradiotherapy in Loco-regional Esophageal Squamous Cell Carcinoma Nimotuzumab, radiotherapy, chemoradiotherapy Paclitaxel - Prosthesis Survival | Phase 3 | Unknown | Shandong Cancer Hospital and Institute | 200 | 2015-03-01 | 2016-04-21 |
Implant Capsular Contracture (1) · Neoplasms (1) · Nutrition Disorders (1)
Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Postoperative Complications (4) · Foreign-Body Reaction (1) · Inflammation (1) · Nutritional and Metabolic Diseases (1)
Cefazolin (1) · Cisplatin (1) · Gentamicins (1) · Megestrol Acetate (1) · Olanzapine (1) · Paclitaxel (1) · Radiotherapy (1) · Risedronic Acid (1) · Vancomycin (1) · nimotuzumab (1)
Mikkel Herly (1) · Qingdao Central Hospital (1) · Shandong Cancer Hospital and Institute (1) · University Hospital, Limoges (1)
China (2) · Denmark (1) · France (1)
Jinming Yu, Ph.D, M.D (1) · Mikkel Herly, MD, Ph.D. (1) · Xue Meng, Ph.D, M.D (1)